Barth F - Search Results

1

Mastering tricyclic ring systems for desirable functional cannabinoid activity.

Petrov RR, Knight L, Chen SR, Wager-Miller J, McDaniel SW, Diaz F, Barth F, Pan HL, Mackie K, Cavasotto CN, Diaz P. Petrov RR, et al. Among authors: barth f. Eur J Med Chem. 2013 Nov;69:881-907. doi: 10.1016/j.ejmech.2013.09.038. Epub 2013 Sep 29. Eur J Med Chem. 2013. PMID: 24125850 Free PMC article.

2

International Union of Pharmacology. XXVII. Classification of cannabinoid receptors.

Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. Howlett AC, et al. Among authors: barth f. Pharmacol Rev. 2002 Jun;54(2):161-202. doi: 10.1124/pr.54.2.161. Pharmacol Rev. 2002. PMID: 12037135 Review.

3

The development of cannabinoid antagonists.

Barth F, Rinaldi-Carmona M. Barth F, et al. Curr Med Chem. 1999 Aug;6(8):745-55. Curr Med Chem. 1999. PMID: 10469889 Review.

4

Synthesis and preliminary evaluation of a new fluorine-18 labelled triazine derivative for PET imaging of cannabinoid CB2 receptor.

Hortala L, Arnaud J, Roux P, Oustric D, Boulu L, Oury-Donat F, Avenet P, Rooney T, Alagille D, Barret O, Tamagnan G, Barth F. Hortala L, et al. Among authors: barth f. Bioorg Med Chem Lett. 2014 Jan 1;24(1):283-7. doi: 10.1016/j.bmcl.2013.11.023. Epub 2013 Nov 20. Bioorg Med Chem Lett. 2014. PMID: 24291040

5

Rational design of a novel peripherally-restricted, orally active CB(1) cannabinoid antagonist containing a 2,3-diarylpyrrole motif.

Hortala L, Rinaldi-Carmona M, Congy C, Boulu L, Sadoun F, Fabre G, Finance O, Barth F. Hortala L, et al. Among authors: barth f. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4573-7. doi: 10.1016/j.bmcl.2010.06.017. Epub 2010 Jun 8. Bioorg Med Chem Lett. 2010. PMID: 20584609

6

[Pharmacology of cannabinoid receptors].

Le Fur G, Rinaldi-Carmona M, Barth F, Alexander J. Le Fur G, et al. Among authors: barth f. Bull Acad Natl Med. 2007 Apr-May;191(4-5):933-8; discussion 938-40. Bull Acad Natl Med. 2007. PMID: 18225447 French.

7

Kinetics of human cannabinoid 1 (CB1) receptor antagonists: Structure-kinetics relationships (SKR) and implications for insurmountable antagonism.

Xia L, de Vries H, Yang X, Lenselink EB, Kyrizaki A, Barth F, Louvel J, Dreyer MK, van der Es D, IJzerman AP, Heitman LH. Xia L, et al. Among authors: barth f. Biochem Pharmacol. 2018 May;151:166-179. doi: 10.1016/j.bcp.2017.10.014. Epub 2017 Nov 2. Biochem Pharmacol. 2018. PMID: 29102677 Free article.

8

Cannabinoids: receptors, endogenous ligands and a newly synthesized antagonist.

Barth F, Mechoulam R, Fride E, Deadwyler S, Martin B. Barth F, et al. NIDA Res Monogr. 1996;162:52-3. NIDA Res Monogr. 1996. PMID: 9066812 No abstract available.

9

SR147778 [5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1H-pyrazole-3-carboxamide], a new potent and selective antagonist of the CB1 cannabinoid receptor: biochemical and pharmacological characterization.

Rinaldi-Carmona M, Barth F, Congy C, Martinez S, Oustric D, Pério A, Poncelet M, Maruani J, Arnone M, Finance O, Soubrié P, Le Fur G. Rinaldi-Carmona M, et al. Among authors: barth f. J Pharmacol Exp Ther. 2004 Sep;310(3):905-14. doi: 10.1124/jpet.104.067884. Epub 2004 May 6. J Pharmacol Exp Ther. 2004. PMID: 15131245

10

Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist.

Rinaldi-Carmona M, Barth F, Héaulme M, Alonso R, Shire D, Congy C, Soubrié P, Brelière JC, Le Fur G. Rinaldi-Carmona M, et al. Among authors: barth f. Life Sci. 1995;56(23-24):1941-7. doi: 10.1016/0024-3205(95)00174-5. Life Sci. 1995. PMID: 7776817

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

138 results

Search Page